Purpose There is evidence that the link between obesity and cardiovascular disease might relate to inflammation in both fat tissue and the arterial wall.
F-FDG uptake on PET is a surrogate marker of vessel wall inflammation. The aim of the study was to measure FDG uptake in both regions using PET and identify links between adipose and arterial inflammation. Methods Included in the study were 173 cardiovascular patients who were prospectively imaged with FDG PET/CT. Arterial FDG uptake was measured in the carotid arteries and ascending aorta. The same was done in fat tissue in the neck, the presternal region (both subcutaneous) and the pericardium. FDG uptake was quantified as average maximal target-to-background ratio ( mean TBR max ). Multivariate regression analyses were performed to identify significant associations between arterial and adipose tissue FDG uptake and clinical variables as given by the standardized correlation coefficient (β).
Results FDG uptake values in all fat tissue regions were highly predictive of vascular FDG uptake in both the carotids (β 0.262, p<0.0001, in the neck subcutaneous region) and aorta (β 0.22, p=0.008, in the chest pericardial region; β 0.193, p=0.019, in the chest subcutaneous region). Obesity was significantly associated with elevated FDG uptake in adipose tissue (β 0.470, p<0.0001, in the neck subcutaneous region; β 0.619, p=0.028, in the chest subcutaneous region; β 0.978, p=0.035, in the chest pericardial region).
Introduction
Obesity, the most common nutritional disorder in industrial countries, is associated with increased cardiovascular mortality and morbidity [1] [2] [3] [4] . Recent data suggest that metabolic and cardiovascular disease in human obesity is mediated by inflammation of adipose tissue driven by monocyte/ macrophage infiltration and overproduction of proatherogenic cytokines [5] [6] [7] . Furthermore, chronic activation of the immune system has been strongly implicated in the pathogenesis of obesity-associated disorders, including type 2 diabetes mellitus and cardiovascular disease, and is a growing target of interest for therapeutic intervention [5, 8] . It is also likely that proinflammatory changes in fat tissue are linked to vascular endothelial dysfunction [2] . Supporting this pathophysiological link, several previously published studies have demonstrated that the accumulation of fat around the heart is associated with an increased risk of both coronary artery disease (CAD) and vascular calcification [9] [10] [11] [12] [13] . However, the underlying mechanisms of this association remain unknown [9] . 18 F-FDG PET reflects the metabolic rate of glucose, a process known to be enhanced in inflamed tissue. Vascular FDG uptake has been shown to be significantly associated with both the degree of macrophage infiltration and the levels of inflammatory gene expression in atherosclerotic plaque [14] [15] [16] . Likewise, FDG PET can also noninvasively image the metabolic activity in visceral and subcutaneous fat tissue and might therefore serve as a surrogate marker of fat tissue inflammation [17, 18] . Previously published studies investigating the impact of cardiovascular risk factors on vascular FDG uptake have revealed that obesity and the metabolic syndrome are among the most important risk factors for vascular inflammation [4, 19, 20] . However, no data have been published so far on the potential link between FDG uptake in fat tissue and that in the vasculature.
Therefore, the aim of this study was to evaluate whether the degree of FDG uptake in different fat tissue regions (FTRs) is linked to FDG uptake in the carotid arteries and aorta and, furthermore, to identify cardiovascular risk factors that might be associated with elevated arterial and fat tissue FDG uptake.
Materials and methods

Study design
This was a prospective imaging study, investigating the impact of the FDG uptake in different FTRs on the prevalence of carotid and aortic wall inflammation assessed by FDG PET. The study, approved by the institutional review board, was conducted from February 2006 until April 2011 at the Mount Sinai School of Medicine, New York, USA. All subjects gave written informed consent.
Men and women with a diagnosis of cardiovascular disease or with multiple cardiovascular disease risk factors were recruited. The definition of cardiovascular disease was previous myocardial infarction, stroke, transient ischaemic attack, history of peripheral artery disease or a history of a coronary revascularization procedure. Patients with fasting glucose levels≥11.1 mmol/l, previous carotid surgery, known vasculitis and/or malignancies were excluded from the study. Patients with the incidental finding of previously unknown vasculitis on the PET scan were excluded from further analyses.
Questionnaire, biometric and biochemical measurements
We assessed the presence of cardiovascular risk factors, use of medication, and family history of cardiovascular disease using a questionnaire. The presence of hypertension was defined as a history systolic blood pressure >140 mmHg, or a diastolic blood pressure >90 mmHg. Diabetes was defined as documented diagnosis of type 1 or 2 diabetic disease and the use of antidiabetic treatment (diet, or oral or insulin treatment). Weight and height were measured to calculate body mass index (BMI). Smoking was defined as smoking at least one cigarette on a daily basis. Fasting glucose levels were obtained by fingerstick blood glucose measurements (Accu-Chek™ Advantage™; Roche Diagnostics, Indianapolis, IN) prior to FDG administration.
FDG PET/CT imaging FDG PET/CT was performed after an overnight fast using a 16-slice PET/CT scanner (LightSpeed Discovery™ ST; GE Healthcare, Milwaukee, WI). FDG was administered intravenously (558.7±96.2 MBq) and patients rested comfortably for approximately 90 to 120 min. To exclude any impact of the outside temperature on the fat tissue assessment with FDG PET, i.e. activation of brown fat tissue, we ensured that the temperature in the room in which the patients were injected and afterwards waiting until the start of the PET acquisition was consistent during summer and winter time. Furthermore, patients were admitted to the PET facility a couple of hours before FDG was injected because of the administrative work, including measurement of height and weight of the patients, taking the history of the patients, etc., which had to be done before the PET study. At the time of FDG injection, the patient's body temperature was therefore appropriately adapted to the room temperature.
The ascending aorta was imaged first and covered the area from the heart to the aortic arch as the upper limit, over 15 -30 min acquisition time (one or two bed positions) depending on the patient's anatomy. Afterwards, the subject's head was placed into a holder for imaging of the carotids. Images from one bed position (15.5 cm) with coverage extending inferior to the internal auditory meatus were acquired for 15 min. We chose two separate acquisitions to improve image quality with arms up for the aorta acquisition and arms down for the carotid acquisition.
A low-dose CT scan (140 kV, 80 mA, and 4.25 mm slice thickness) was performed for attenuation correction and coregistration. No CT contrast agent was administered. The absence of CT contrast was deliberate, to allow those with renal impairment to be imaged. The main studies of reproducibility also did not use contrast CT, but nevertheless showed excellent reproducibility [4, 21] .
Vessel image analysis
Images were analysed on a dedicated commercially available workstation (Extended Brilliance™ Workspace V4.0.0.3206; Philips Medical Systems Inc., Cleveland, OH). One experienced reader (J.B.) analysed all scans. The methodology for the analysis and reproducibility of the measurements have been previously reported in detail [4] . Briefly, arterial FDG uptake was quantified by manually drawing a region of interest (ROI) around each common carotid artery and the ascending aorta, including the vessel lumen, on every slice of the coregistered transaxial PET/CT images. Next, the maximum arterial standardized uptake value (SUV; highest pixel activity within the ROI) was determined. The SUV is the decay-corrected tissue concentration of FDG in kilobecquerels per millilitre, adjusted for the injected FDG dose and the body weight of the patient. By averaging the maximum SUVs of all arterial slices of the left and right carotid artery and the ascending aorta, a mean SUV max value was derived for all arteries.
The arterial target-to-background ratio (TBR) was calculated by normalizing the arterial SUV to the blood pool activity by dividing the SUVs in the arteries by the average blood mean SUV estimated from both jugular veins (carotid SUVs) or the superior vena cava (aortic SUVs), respectively. Choosing two different veins optimally reflected the respective FDG blood pool activity at the time of the aortic or carotid data acquisition, respectively, because each of them was scanned in the respective field of view with the corresponding artery. FDG blood pool analysis was done by placing at least six ROIs of 3 -4 mm in consecutive slices of the respective vein and averaging the mean SUVs obtained. The TBR is a blood-normalized arterial SUV, considered to be a reflection of arterial FDG uptake and underlying macrophage activity [22] . The arterial TBR values obtained were then averaged in order to derive a mean TBR max for both carotid arteries and the ascending aorta.
Fat tissue image analysis
FTRs, defined as subcutaneous fat tissue in the neck (NeckSub) and in the presternal area (ChestSub) as well as pericardial fat tissue (ChestPeri), were identified based on predefined ranges of Hounsfield unit values (−70 to −110 HU) from CT images as previously described [17] . After fusion of the CT and PET images, ROIs were placed on three consecutive slices whenever possible and mean and maximal SUVs across these slices were averaged (Fig. 1) . To reduce the possibility of FDG uptake by brown fat tissue and/or physiological FDG uptake in the myocardium affecting the FDG uptake values of the different FTRs, ROIs were placed away from regions of fat tissue with focally increased FDG uptake or in regions with diffusely increased FDG uptake with SUVs close to or above 1.5, which are usually considered to reflect brown fat tissue [23] . A cut-off SUV of 2.0 can be considered to represent the lower boundary of activity in patients with detectable brown adipose tissue according to a recently published study of the method of FDG uptake into brown fat tissue, and it was seen to be more than two standard deviations above the maximal SUV seen in typical depots of white adipose tissue [23] . However, to exclude an impact of FDG uptake into brown fat tissue on the subcutaneous and pericardial white fat tissue ROIs to the highest degree, we decided to use an even lower SUV cut-off value of 1.5, and not to place ROIs in FTRs with FDG uptake close to this threshold.
ROIs in the pericardial fat region were placed in the substernal mediastinal region of the chest cranial to the heart, and therefore as far away as possible from the myocardium and the large vessels (e.g. the aortic arch) in order to exclude overspill from the myocardial and/or vascular FDG uptake into the pericardial FTR (Fig. 1) . Furthermore, ChestPeri ROIs were not placed at all if such an overspill could not be excluded to the highest possible degree. As this was rarely the case, mainly in patients with a pretty high myocardial FDG uptake, in approximately 90 % (88.4 %, Table 3 ) of patients pericardial fat tissue ROIs could be appropriately placed without suspicion of an overspill from any vascular and/or myocardial FDG uptake. ROI diameters for all FTRs were more than at least 6 mm. Concerning the vascular SUVs, fat tissue SUVs of the neck region were corrected by the blood pool activity of the jugular veins, and the two other FTRs by SUV values of the superior vena cava in order to obtain fat tissue TBR values, which we assumed reflected the true metabolic activity and/or the inflamed state of fat tissue cells.
Statistical analysis
All continuous variables are expressed as means±standard deviation and categorical data as absolute numbers and percentages throughout . In general, the normality of the distribution of data was tested for all the different statistical calculations using the Kolmogorov-Smirnov test. The FDG uptake parameters of the different FTRs were compared using ANOVA with appropriate correction for multiple comparisons using Tukey post-hoc testing.
Multiple regression with backward elimination and linear regression with ENTER method
Multiple linear regression analysis with backward elimination was used to assess the association between the cardiovascular risk factors including the FDG uptake values in all FTRs and the vascular FDG uptake parameters ( mean TBR max values for both). Vascular mean TBR max values were treated as the response variables (dependent) and the cardiovascular risk factors as the explanatory (independent) variables for the regression analysis. The explanatory variables included were: age, male gender, BMI, diabetes, history of cardiovascular disease, smoking, alcohol use, hypertension, family history of cardiovascular disease and the different FTR mean TBR max values. Following this, EN-TER regression was used to determine independent predictors of the response variables. For this method, all the explanatory variables of the backward elimination model that showed a significant association with the vascular mean TBR max value (p<0.10) were retained and entered into the regression model in a block in a single step. This entry method was preferred over the forward selection of variables since after excluding all the explanatory variables without a significant association with the carotid or aortic mean TBR max value, respectively, only a few significant variables were left for a relatively low number of cases. All results of the multiple regression models are provided here with the standardized regression coefficient (β), the 95 % confidence interval, and the p value for estimating the statistical significance.
In order to identify potential associations between clinical variables and the FDG uptake in the different FTRs, age, BMI, hypertension, male gender, diabetes, smoking, and alcohol use served as explanatory variables, while the mean TBR max value in the respective FTR was treated as the dependent variable. To more specifically evaluate the impact of body habitus on the degree of FDG uptake in fat tissue, we calculated the body surface area (BSA) for each patient following the formula of DuBois and DuBois (0.20247 × height in metres 0.725 × weight in kilograms 0.425 ; BSA DuBois) as well as the percent deviation from the individual normal Broca value: i.e. height in centimetres − 100; deviation [(body weight in kilograms × 100)/individual normal Broca value − 100] [24] . Both variables were also entered into the regression analyses as explanatory variables.
All statistical analyses were performed using SPSS™ statistical package 16.0 (SPSS Inc., Chicago, IL). 
Results
Population characteristics
Included in the study were 173 patients. Table 1 shows the characteristics of the included patients. The numbers of patients in whom the different FDG uptake analyses of the carotid and aortic vessel walls and the FTRs could be performed are shown in Table 2 .
Exclusion of patients for distinct parts of the FDG uptake analyses was due to FDG uptake spill over from surrounding tissues and/or the inability to adequately place the ROI within the target tissue.
FDG PET imaging results
The imaging analyses are given in Table 2 . ChestPeri mean TBR max values were significantly higher than the respective FDG uptake parameters of the two subcutaneous FTRs (p<0.0001 for all comparisons). No further statistically significant differences in the FDG uptake values between the different FTRs were observed. Tables 3 and 4 show the results of the multiple linear regression analyses to identify clinical risk factors associated with FDG uptake parameters (i.e. measures of plaque inflammation) of the carotids and the ascending aorta. After retaining the significant explanatory variables from the backward elimination model, FDG uptake in the NeckSub region was significantly associated with the mean TBR max values of the carotids in the ENTER regression model (Table 3 , Fig. 2a) . Accordingly, age, male gender and history of cardiovascular disease were found to be significantly associated with the FDG mean TBR max values in the carotids. Furthermore, a significantly negative association with diabetes was seen in the ENTER regression model.
Risk factors for increased vascular FDG uptake
After retaining the significant explanatory variables (p<0.10) from the aortic backward model in the ENTER regression model, ChestPeri mean TBR max , ChestSub mean TBR max, BMI, and male gender were found to be significantly associated with the mean TBR max of the aorta (Table 4 , Fig. 2b ).
Risk factors for increased fat tissue FDG uptake
After retaining the variables from the initial backward regression model significantly associated with the FDG uptake in the different FTRs, the ENTER regression model revealed that BSA DuBois was significantly associated with NeckSub mean TBR max and ChestSub mean TBR max (Tables 5 and 6 ). In contrast, BSA DuBois was not significantly association with ChestPeri mean TBR max (Table 7) . However, deviation from the Values are means±SD or n (%)
normal Broca values was indeed the only significant risk factor for intrathoracic fat tissue FDG uptake. Furthermore, diabetes was negatively associated with the ChestPeri mean TBR max (Table 7) , and BMI was significantly negatively association with NeckSub mean TBR max (Table 5) .
Discussion
The aim of this study was to determine if the degree of FDG uptake in different FTRs showed a significant association with vessel wall inflammation in the carotid arteries and aorta as indicated by FDG PET/CT in a population of patients with known cardiovascular disease or multiple risk factors for it.
We also tried to identify clinical variables significantly associated with increased FDG uptake in the FTRs. We prospectively performed FDG PET imaging in a large sample population with protocols optimized for vessel wall FDG uptake [22, 25] . FDG uptake in the different FTRs was significantly associated with the mean TBR max in the carotid and the aortic wall. Additionally, increasing body weight, expressed in terms of BSA values and abnormally increased deviations from the normal Broca value, was the most important risk factor for increasing mean TBR max in different FTRs. Surprisingly, we also found a negative association between BMI and the mean TBR max values in the NeckSub, a finding that we cannot finally explain, mainly because of the positive and highly significant correlation of the two other body mass parameters (BSA, Broca value) and the FDG uptake in those FTRs. However, these findings might indeed reflect the known phenomenon termed the "obesity paradox" in which a decreased cardiovascular risk is associated with increasing BMI values and which might be more pronounced in body regions with a higher fat burden such as the abdomen. Additionally, it might also reflect the fact that the BMI is not the optimal surrogate marker for pathological overweight as it lacks the discriminatory power to differentiate between body fat and lean mass [26] .
Rationale for evaluating fat tissue FDG uptake
Most clinical studies to date have used volumetric quantification of fat depots by CT or MRI to evaluate associations with cardiovascular risk [11] [12] [13] 17] . However, a preliminary report by Brunken et al. suggested that volumetric measurements alone may not be sufficient, and could be improved by using functional imaging with PET to determine the metabolic activity in fat tissue [17, 27] . Furthermore, functional differences between subcutaneous and visceral fat tissue are well known [28] . For example, genes for angiotensinogen (blood pressure regulation), complement factors, and fatty acid-binding protein 4 (involved in fatty acid trapping in Continuous variables are expressed as means±SD and categorical data as absolute numbers and percentages. By averaging the maximum SUVs of all arterial slices of the left and right carotid arteries as well as of the ascending aorta, the mean SUVs for the carotid arteries and the ascending aorta were derived. By averaging the mean SUVs of all analysed slices of the left and right jugular veins and the superior vena cava, the mean SUVs for the FDG blood pool activities were derived. The SUVs of the carotids and the subcutaneous fat tissue in the neck are corrected for the FDG blood pool activity in the jugular veins in order to provide the TBR values, and the SUVs of the aorta and the subcutaneous and pericardial chest fat tissue are corrected for the FDG blood pool activity in the superior vena cava a Slices that provided sufficient and appropriate information and were included in further analysis. The total number of analysed slices might have been higher due to exclusion of slices for which appropriate placement of the arterial ROI and FDG overspill from surrounding structures into the arterial ROI could not be excluded b Time between FDG injection and start of data acquisition adipocytes), are expressed at higher levels in visceral adipose tissue than in subcutaneous fat [28] [29] [30] . These differences were highlighted in a study by Christen et al., in which higher FDG uptake values were shown in visceral than in subcutaneous adipose tissue, implying higher metabolic activity within visceral fat [17] . Furthermore, earlier studies by Virtanen et al. also showed higher rates of glucose uptake in visceral than in subcutaneous adipose tissue in groups of healthy and diabetic men under euglycaemic conditions [18, 31] . These findings are comparable with the results of the current study, as we found significantly higher FDG uptake values in pericardial fat tissue than in the two different subcutaneous FTRs. Christen et al. also attempted to identify the cellular and molecular mechanisms underlying differential fat tissue glucose uptake. They noted increased glucose uptake within stromal regions taken from visceral adipose tissue compared to those from subcutaneous adipose tissue [17] . These stromal areas are known to contain inflammatory cells such as macrophages and T cells. Christen et al. suggested that the increase in glucose uptake in visceral adipose tissue might be explained by the increased expression of HK-1 (hexokinase-1, an enzyme facilitating phosphorylation of glucose) in visceral adipose tissue derived stromal vascular cells [17] . Interestingly, despite the well-known association between obesity and inflammation, no difference in FDG uptake in visceral adipose tissue was found between lean and obese individuals in their study. In another supportive study in a similar CVD population to the one in our study, Elkhawad et al. found higher baseline FDG uptake values in visceral than in subcutaneous fat tissue. In addition, there was also a more profound reduction in uptake of FDG in visceral than in subcutaneous fat tissue following high-dose treatment with losmapimod, a p38 mitogen-activated protein kinase inhibitor [32] . Fat tissue FDG uptake and carotid and aortic wall inflammation
We found FDG uptake in the different FTRs the most consistent and among the most important risk factors for vascular FDG uptake, both in the carotids as well as in the aorta. As expected and in part previously reported by our group, diabetes showed negative associations with some of the vascular and FTR FDG uptake parameters, a fact that might most likely be due to a competitive effect between increased glucose levels in these diabetic patients and the FDG uptake in the vessels [20] . Prospective cohort studies as well as national surveys have shown that obese individuals have an increased risk of several adverse health outcomes, notably hypertension, diabetes, cardiovascular disease, arthritis, disability, and mortality. With regard to cardiovascular disease, it has also been shown that mean intima media thickness of the internal carotid arteries, a marker of atherosclerosis, increases with increasing BMI [33, 34] . Furthermore, significant associations exist among body weight, presence of metabolic syndrome and vascular FDG uptake [4, 19] .
Though obesity has been characterized as a chronic inflammatory disease and atherosclerosis is now widely accepted as a vascular inflammatory disorder, scientific investigation has only recently started to focus on the underlying mechanisms linking obesity and atherosclerosis. These mechanisms are, however, still poorly understood [30] . In contrast, monocytes and monocyte-derived macrophages are known to be cellular hallmarks in the pathogenesis of atherosclerosis [35] . Recently, animal studies have demonstrated a specific contribution of certain monocyte subsets to atherogenesis and, additionally, an obesity-associated macrophage accumulation in adipose tissue [36] [37] [38] . Furthermore, it has also been shown that patients with CAD have a shift in monocyte subsets towards CD16+ monocytes compared to healthy controls [39] . These findings indicate for the first time a common role of CD16+ monocytes in the pathogenesis of obesity and atherosclerosis. The recently published I LIKE HOMe study has revealed a significant association between counts of CD16+ monocytes and both obesity and subclinical atherosclerosis in a large cohort of healthy individuals [40] . This association between CD16+ monocytes and obesity confirms previously published results showing a shift towards CD16+ monocytes in morbidly obese patients [41] . In another study also published in 2010, Wu et al. found CD11c, a β2-integrin, to be increased in obese humans with metabolic syndrome compared to lean controls [42, 43] . The results of the current study seem to confirm these findings, as we found that deviations from the normal individual body weight, as indicated by increasing BSA and abnormal Broca values, was the only variable consistently showing a significant association with the FDG uptake in all of the different FTRs. CD11c increases monocyte adhesion to inflamed endothelial cells and has been used as an activation marker for monocytes/ macrophages [44] . Furthermore, CD11c+ leucocytes in adipose tissue of mice have shown proinflammatory characteristics of classically activated macrophages [45] . Blood monocyte CD11c has been shown to increase in hyperlipidaemia and to play an important role in the development of atherosclerosis in apolipoprotein E-deficient mice [43] . The functional consequence of increased CD11c on adipose tissue leucocytes and blood monocytes in obesity may be related to enhanced accumulation and/or activation of macrophages and/or dendritic cells in both adipose tissue and the arterial wall. This may contribute to T-cell accumulation and activation, thereby accelerating adipose tissue inflammation and atherogenesis, and contributing to the higher risk for atherosclerotic cardiovascular disease in obese individuals [42] . The most recently published data by Hirata et al. are in line with this as they found a significantly enhanced infiltration of macrophages and expression of pro-and antiinflammatory cytokines in epicardial fat of patients with CAD compared with that of patients without CAD [46] . Additionally, the ratio of M1 to M2 macrophages was positively correlated with the severity of CAD. Furthermore, the expression of proinflammatory cytokines was positively correlated, and the expression of antiinflammatory cytokines was negatively correlated with the ratio of M1 to M2 macrophages in epicardial adipose tissue of patients with CAD. By contrast, there was no significant difference in macrophage infiltration and cytokine expression in subcutaneous adipose tissue between the CAD and non-CAD groups. The results of our study in part confirm their results as we found a significant association between pericardial fat tissue FDG uptake and vascular FDG uptake in the aorta.
Limitations
With regard to the FDG uptake in the FTRs, we cannot totally exclude an impact of high insulin levels, as frequently seen in obese subjects with increased blood glucose levels, on the degree of fat tissue FDG uptake as found by Virtanen et al. after insulin stimulation [18] . However, we did not have patient's insulin levels available in the current study, but we did not see any correlation between patients fasting glucose and BMI values (data not shown). This therefore should lower the effect of increased insulin levels on the increase in fat tissue FDG uptake in obese patients to some degree. Nevertheless, this issue clearly needs to be addressed in future studies.
As we did not use contrast-enhanced CT in the current study, soft plaques in the vessels could not be detected. The absence of CT contrast was deliberate, to allow those with renal impairment to be imaged. However, by intention, we chose a population either with defined atherosclerosis (e.g. known CAD, carotid artery disease, etc.) or multiple risk factors for it, and we included all evaluable slices of the arterial wall. Thereby, both focal and diffuse areas of FDG uptake were included in the analyses. Furthermore, subjects with known vasculitis were excluded, and we made the assumption that any FDG signal within the vessel wall was likely to be due to accumulation of the tracer within atherosclerotic plaque. Others have previously demonstrated colocalization between lipid-rich plaque and FDG uptake [47] .
Several further limitations of our study need to be addressed. Firstly, we did not obtain serum lipid levels, markers of glucose metabolism or serum inflammatory markers. Mainly regarding the latter point, markers such as hs-CRP and Lp-PLA2 would have given more information as to whether the link between fat and vascular FDG uptake reflects a more systemic proinflammatory state or a fat-specific phenomenon. As we did not find any association between statin therapy and vascular or fat tissue FDG uptake in our patient population (data not shown) a trend towards a more fat-specific phenomenon has at least to be considered. However, this has to be addressed in a future study. As we mainly intended to evaluate the pericardial FTR compared to different subcutaneous FTRs, we are also lacking data on the FDG uptake in abdominal visceral FTRs. Secondly, it is unknown if fat tissue FDG uptake is predictive of progression of vascular disease or future cardiovascular events.
We are aware of the fact, that a potential overspill of FDG uptake into surrounding tissues might impact the FDG uptake in the different fat tissue ROIs. This is mainly of importance for the pericardial fat tissue analysis, which might have been affected by physiological FDG uptake into the myocardium. However, as described in the Materials and methods section, we placed the fat tissue ROIs as far away from other structures as possible and did not place ROIs for which we could not exclude an overspill at the highest degree. Furthermore, we used well-accepted FDG uptake thresholds to exclude placement of ROIs into brown FTRs instead of into white fat tissue as indicated [23] . We also avoided an effect of outside temperature on fat tissue assessment with FDG PET with respect to brown fat tissue activation. However, because analysis of fat tissue FDG uptake is an emerging field with few data available, future studies clearly need to address the issue of the optimal placement of ROIs for quantification of fat tissue metabolic activity as depicted by FDG PET.
By intention, we decided to just analyse the ascending aorta instead of the whole or additional parts of the aorta. This was mainly because of the previously shown higher reproducibility of that part of the aorta but also in order to reduce the radiation exposure to the patients as much as possible [21] .
Conclusion
In the current study we showed that fat tissue FDG uptake is significantly associated with FDG uptake in the wall of the ascending aorta and carotid arteries. Furthermore, increased body weight was the most important and consistent risk factor for FDG uptake in all FTRs. Based on these results, FDG PET/CT seems to be able to noninvasively image the wellknown link between inflammatory fat tissue and vessel wall inflammation.
